A Short Guide and a Forest Plot Command For

The University of Manchester Research

A short guide and a forest plot command (ipdforest) for one-stage meta-analysis

Link to publication record in Manchester Research Explorer

Citation for published version (APA): Kontopantelis, E., & Reeves, D. (2012). A short guide and a forest plot command (ipdforest) for one-stage meta- analysis. In host publication

Published in: host publication

Citing this paper Please note that where the full-text provided on Manchester Research Explorer is the Author Accepted Manuscript or Proof version this may differ from the final Published version. If citing, it is advised that you check and use the publisher's definitive version.

General rights Copyright and moral rights for the publications made accessible in the Research Explorer are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.

Takedown policy If you believe that this document breaches copyright please refer to the University of Manchester’s Takedown Procedures [http://man.ac.uk/04Y6Bo] or contact [email protected] providing relevant details, so we can investigate your claim.

Download date:11. Oct. 2021 Health Sciences Primary Care Research Group necessary.] if title, [Add [Add CONCLUSIONS: [Add text here.] RESULTS: [Add text here.] METHODS: [Add text here.] OBJECTIVE: [Add text here.] BACKGROUND: [Add text here.] TITLE

[Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace, text :

here.] Outline

Label

Four BACKGROUND

[Repeat objective from from above.] objective [Repeat

OBJECTIVE ABSTRACT Label Three Label One

4 3 2 1

Label

Two hr ud n oetpo omn for command plot forest a and guide short A

ipdforest guide practical A overview Meta-analysis Summary example methods [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,     necessary.]if title, [Add    necessary.]if title, [Add [Add title, if necessary.]if title, [Add [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] ...... [Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub Lorum(kg) Wt ------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet] Nostrud: N Nostrud: Ipsum(wk)

F Unknown Unknown

W HB Irure: B Irure: O Proident H n-tg eaaayi nStata in meta-analysis one-stage

Lorem

Excepteur METHODS

101 (476%) 121 (571%) 172 (811%) 18 (SD 10) 18 (SD 106 (50%) 79 (373%) 22 (104%) 31 ( 18 (85%) (n=212) 5 (24%) 9 (42%) 1 (05%) 2 (09%) Lkl SD 0

Sint

[Replace the followingnames andtitles with thoseof the actual contributors:HelgeHoeing, PhD

vnKnoatlsDvdReeves David Kontopantelis Evan

18 (667%) 26 (963%) 37 (SD 2) 37 (SD Controls 10 (37%) 17 (63%) 7 (259%)

1 (37%) 1 (37%) 1 (37%) (SD 07) (SD (n=27) 29 0 0 0

1 [Add affiliationfor firstcontributor], eaaayi overview Meta-analysis eaaayi overview Meta-analysis otpnei,Reeves Kontopantelis, Reeves Kontopantelis, the S nulConference Annual RSS [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,      [Add title,if necessary.] 2 2nd Qtr2nd 2nd Qtr2nd Qtr2nd 3rd Qtr 3rd 3rd Qtr 3rd Qtr 3rd [Add affiliation[Add forcontributor], second 4th Qtr 4th 4th Qtr 4th Qtr 4th 1st Qtr 1st 1st Qtr 1st Qtr 1st [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] rcia guide practical A rcia guide practical A 0% 0% 0% [Poster title] nttt fPplto Health Population of Institute efr,5Sp2012 Sep 5 Telford,

20% 20% 20% ipdforest nvriyo Manchester of University etefrPiayCare Primary for Centre RESULTS 40% 40% 40% 1 ; Carol Philips,PhD 3 [Add affiliationfor third contributor], 60% 60% 60% Summary Summary aut fMedicine of Faculty ipdforest ipdforest

80% 80% 80%

2 ; Jonathan Haas, RN, BSN, MHA BSN, RN, Haas, Jonathan ;

100% 100% 100% 4 [Add affiliationfor fourthcontributor] 3 , and, KimberlyB. Zimmerman, MD [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace, [E organization] or [Institution [Department] [Name] contact: please information additional For . . . . . list as[Add bulleted text ora paragraph.]     necessary.]if title, [Add

[Add title, if necessary.]if title, [Add title] [Graphic - mail address] mail [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] ......

[Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub

------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet]

ipdforest ipdforest

CONCLUSIONS title] [Graphic

RESULTS 4

command

title] [Graphic

Health Sciences Primary Care Research Group necessary.] if title, [Add [Add CONCLUSIONS: [Add text here.] RESULTS: [Add text here.] METHODS: [Add text here.] OBJECTIVE: [Add text here.] BACKGROUND: [Add text here.] TITLE

[Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace, text :

here.] Timeline eaaayigrpre td results study reported Meta-analysing

Label

Four BACKGROUND

[Repeat objective from from above.] objective [Repeat

OBJECTIVE ABSTRACT Label Three Label One

Label

Two

niiulsuisfrteproeo nertn the integrating of findings" purpose from the results for analysis studies of a individual collection describe large to a term of the analysis used first Glass 1976 In a ulse n1955 intervention in therapeutic published a was assessed that attempt first The as far as back studies individual 1904 from results pool to Efforts oee,polm fe arise often problems However, so ‘after’, meaning meta-analysis preposition Greek a is ‘Meta’ w-tg process two-stage A [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,     necessary.]if title, [Add    necessary.]if title, [Add [Add title, if necessary.]if title, [Add [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] ...... [Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub td ih etodfeett eicue (population included be to heterogeneous) different clinically too precision be of might loss study a which a with size transformed effect be the to than needs other statistic a report papers required information statistical input the as all report not do papers sn utbemt-nlssmodel estimate meta-analysis effect suitable overall a an using into combined then are studies these included the from on extracted papers are published statistics effect summary relevant the Lorum(kg) Wt ------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet] Nostrud: N Nostrud: Ipsum(wk)

F Unknown Unknown

W HB Irure: B Irure: O Proident H

Lorem

Excepteur METHODS

101 (476%) 121 (571%) 172 (811%) 18 (SD 10) 18 (SD 106 (50%) 79 (373%) 22 (104%) 31 ( 18 (85%) (n=212) 5 (24%) 9 (42%) 1 (05%) 2 (09%) Lkl SD 0

Sint

[Replace the followingnames andtitles with thoseof the actual contributors:HelgeHoeing, PhD

18 (667%) 26 (963%) 37 (SD 2) 37 (SD Controls 10 (37%) 17 (63%) 7 (259%)

1 (37%) 1 (37%) 1 (37%) (SD 07) (SD (n=27) 29 0 0 0

1 [Add affiliationfor firstcontributor], eaaayi overview Meta-analysis eaaayi overview Meta-analysis otpnei,Reeves Kontopantelis, Reeves Kontopantelis, = [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,      [Add title,if necessary.] 2 2nd Qtr2nd 2nd Qtr2nd Qtr2nd 3rd Qtr 3rd 3rd Qtr 3rd Qtr 3rd [Add affiliation[Add forcontributor], second 4th Qtr 4th 4th Qtr 4th Qtr 4th 1st Qtr 1st 1st Qtr 1st Qtr 1st [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] ⇒ rcia guide practical A rcia guide practical A 0% 0% 0% [Poster title]

20% 20% 20% RESULTS 40% 40% 40% post-analysis 1 ; Carol Philips,PhD 3 [Add affiliationfor third contributor], 60% 60% 60% Summary Summary ipdforest ipdforest

80% 80% 80%

2 ; Jonathan Haas, RN, BSN, MHA BSN, RN, Haas, Jonathan ;

[Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub

------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet]

ipdforest ipdforest

CONCLUSIONS title] [Graphic

RESULTS 4

title] [Graphic

"statistical Health Sciences Primary Care Research Group necessary.] if title, [Add [Add CONCLUSIONS: [Add text here.] RESULTS: [Add text here.] METHODS: [Add text here.] OBJECTIVE: [Add text here.] BACKGROUND: [Add text here.] TITLE

[Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace, text :

here.] IPD Data Patient Individual oetplot Forest

Label

Four BACKGROUND

[Repeat objective from from above.] objective [Repeat

OBJECTIVE ABSTRACT Label Three Label One

Label

Two

acltdadcetn oetpo sntstraightforward not is forest-plot a is creating effect overall and the calculated only meta-analysis, one-stage In process two-stage or single- a in analysed be Can each from available IPD are when study avoided be can problems These ovyifraingahclytruhafrs plot forest to a ability through the graphically is information convey meta-analysis two-stage of advantage One [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,     necessary.]if title, [Add    necessary.]if title, [Add [Add title, if necessary.]if title, [Add [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] ...... [Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub ehdbiga eteuvln ncranscenarios certain in equivalent two-stage best the at with being approach, method best the currently stage is single this a in combine studies to across used information be can models regression mixed-effects controlling covariate patient-level subgroup and with analyses addressed be can heterogeneity clinical standardised easily be can outcomes Enter performed when are presented meta-analyses always two-stage and meta-analysis of experience feature methodological key no or for little useful with particularly readers and follow to all the easy across of informative, and strength study relative each the in demonstrate process,intervention to the used of be stage can ﬁrst and the after available effects study Lorum(kg) Wt ------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet] Nostrud: N Nostrud: Ipsum(wk)

F Unknown Unknown

W HB Irure: B Irure: O Proident H

Lorem

Excepteur METHODS

101 (476%) 121 (571%) 172 (811%) 18 (SD 10) 18 (SD 106 (50%) 79 (373%) 22 (104%) 31 ( 18 (85%) (n=212) 5 (24%) 9 (42%) 1 (05%) 2 (09%) Lkl SD 0

Sint

[Replace the followingnames andtitles with thoseof the actual contributors:HelgeHoeing, PhD

18 (667%) 26 (963%) 37 (SD 2) 37 (SD Controls 10 (37%) 17 (63%) 7 (259%)

1 (37%) 1 (37%) 1 (37%) (SD 07) (SD (n=27) ipdforest 29 0 0 0

1 [Add affiliationfor firstcontributor], eaaayi overview Meta-analysis eaaayi overview Meta-analysis otpnei,Reeves Kontopantelis, Reeves Kontopantelis, [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,      [Add title,if necessary.] 2 2nd Qtr2nd 2nd Qtr2nd Qtr2nd 3rd Qtr 3rd 3rd Qtr 3rd Qtr 3rd [Add affiliation[Add forcontributor], second 4th Qtr 4th 4th Qtr 4th Qtr 4th 1st Qtr 1st 1st Qtr 1st Qtr 1st [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] rcia guide practical A rcia guide practical A 0% 0% 0% [Poster title]

20% 20% 20% RESULTS 40% 40% 40% 1 ; Carol Philips,PhD 3 [Add affiliationfor third contributor], 60% 60% 60% Summary Summary ipdforest ipdforest

80% 80% 80%

2 ; Jonathan Haas, RN, BSN, MHA BSN, RN, Haas, Jonathan ;

[Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub

------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet]

ipdforest ipdforest

CONCLUSIONS title] [Graphic

RESULTS 4

title] [Graphic

[Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace, text :

here.] h yohtclstudy hypothetical The xdcmo necp;rno ramn fet xdefc o baseline for effect ﬁxed effect; treatment random intercept; common ﬁxed 1 Model

Label

Four BACKGROUND

[Repeat objective from from above.] objective [Repeat

OBJECTIVE ABSTRACT Label Three Label One

Label

γ trial for effect group β γ Y j i

Two h trial the : patient the :

1 0 1 i j enteteteffect treatment mean : xdcmo intercept common ﬁxed : j ntemdl htflo,i eea,w eoeﬁxed denote we ‘ general, with in effects follow, that models the In have we trial each For xtmelogit the with models xtmixed random-effects linear explore will We required not is and standardisation trials across consistent measurements Assume trials controlled randomised from data patient Individual h outcome the : admtreatment random : Y β 1 i [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,     necessary.]if title, [Add    necessary.]if title, [Add [Add title, if necessary.]if title, [Add j i [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] j [Add key point.] [Add key point.] [Add key point.] [Add key point.] ...... j [Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub aeieadflo-pdt o h otnosoutcome continuous the covariates for data follow-up and baseline variable membership control/intervention binary a = ru membership group : = Lorum(kg) Wt ------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet] Nostrud: N Nostrud: Ipsum(wk)

F Unknown Unknown

W HB Irure: B Irure: O Proident H

Lorem

Excepteur METHODS γ

γ 101 (476%) 121 (571%) 172 (811%) 18 (SD 10) 18 (SD 106 (50%) 79 (373%) 22 (104%) 31 ( 18 (85%) (n=212) 5 (24%) 9 (42%) 1 (05%) 2 (09%) Lkl SD 0

Sint

0 5)

[Replace the followingnames andtitles with thoseof the actual contributors:HelgeHoeing, PhD 1

18 (667%) 26 (963%) + 37 (SD 2) 37 (SD Controls 10 (37%) 17 (63%) 7 (259%)

1 (37%) 1 (37%) 1 (37%) (SD 07) (SD (n=27) + 29 0 0 0 omn;apiaint h oitccs using case logistic the to application command;

1 [Add affiliationfor firstcontributor], j β u γ eaaayi overview Meta-analysis eaaayi overview Meta-analysis hudb straightforward be should otpnei,Reeves Kontopantelis, otpnei,Reeves Kontopantelis, 1 1 sadrno fet ih‘ with effects random and ’s j j group [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,      [Add title,if necessary.] 2 2nd Qtr2nd 2nd Qtr2nd Qtr2nd 3rd Qtr 3rd 3rd Qtr 3rd Qtr 3rd [Add affiliation[Add forcontributor], second 4th Qtr 4th 4th Qtr 4th Qtr 4th 1st Qtr 1st 1st Qtr 1st Qtr 1st [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] rcia guide practical A rcia guide practical A 0% 0% 0% [Poster title]

20% 20% 20% RESULTS 40% 40% 40% 1 ; Carol Philips,PhD 3 [Add affiliationfor third contributor], 60% 60% 60% Summary Summary i ipdforest ipdforest

j 80% 80% 80%

2 ; Jonathan Haas, RN, BSN, MHA BSN, RN, Haas, Jonathan ;

+ 100% 100% 100% 4 [Add affiliationfor fourthcontributor] γ 2 3 , and, KimberlyB. Zimmerman, MD [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace, [E organization] or [Institution [Department] [Name] contact: please information additional For . . . . . list as[Add bulleted text ora paragraph.]     necessary.]if title, [Add

[Add title, if necessary.]if title, [Add title] [Graphic - mail address] mail [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] Y [Add key point.] [Add key point.] [Add key point.] [Add key point.] ......

[Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub

------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet] b

ipdforest ipdforest

CONCLUSIONS title] [Graphic

RESULTS j 4

title] [Graphic

fetfrtrial for effect u trial σ τ Y γ i i 1 2 1 j 2 j b j 2 ro term error : xdbsln effect baseline ﬁxed : j ihntilvrac for variance trial within : i admtreatment random : ewe ra variance trial between : j aeiescore baseline : j u i 1 j j ∼ β ∼ ’s N N ( ( 0 0 σ , j τ , j 2 1 ) 2 ) Health Sciences Primary Care Research Group necessary.] if title, [Add [Add CONCLUSIONS: [Add text here.] RESULTS: [Add text here.] METHODS: [Add text here.] OBJECTIVE: [Add text here.] BACKGROUND: [Add text here.] TITLE

[Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace, text :

here.] xdcmo necp;rno ramn fet xdefc o baseline for effect fixed effect; treatment random intercept; common fixed 1 Model xdtilseicitret;rno ramn fet xdtilseicefcsfor effects trial-specific fixed effect; treatment baseline random intercepts; specific trial fixed 2 Model

Label

Four BACKGROUND

[Repeat objective from from above.] objective [Repeat

OBJECTIVE ABSTRACT Label Three Label One

Label

Two

nSaaepesdas: expressed Stata In trial: each for intercepts effects fixed different baseline for fixed allows and model accepted more A as expressed be can it Stata In approach simplest the Possibly omnitret&fie aeiedfcl ojustify to difficult baseline fixed & intercept Common [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,     necessary.]if title, [Add    necessary.]if title, [Add [Add title, if necessary.]if title, [Add [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] ...... [Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub tie .ru .tdi b b b Yb4 Yb3 Yb2 Yb1 nocons where i.studyid studyid:group, i.group || Y xtmixed γ where Y effect random a as intercept the that note Y group studyid studyid:group, where || Yb nocons i.group Y xtmixed γ β Lorum(kg) Wt ------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet] Nostrud: N Nostrud: Ipsum(wk)

F Unknown Unknown

W HB Irure: B Irure: O Proident H

0 2 Lorem

and j j j Excepteur METHODS j

101 (476%) 121 (571%) 172 (811%) 18 (SD 10) 18 (SD 106 (50%) 79 (373%) 22 (104%) 31 ( 18 (85%) (n=212) 5 (24%) 9 (42%) 1 (05%) 2 (09%) = h xditretfrtrial for intercept ﬁxed the h xdbsln fetfrtrial for effect baseline ﬁxed the = Lkl SD 0

Sint

[Replace the followingnames andtitles with thoseof the actual contributors:HelgeHoeing, PhD

18 (667%) 26 (963%) 37 (SD 2) 37 (SD Controls 10 (37%) 17 (63%) 7 (259%)

γ 1 (37%) 1 (37%) 1 (37%) (SD 07) (SD (n=27) γ 29 0 0 0

oto/nevninmembership control/intervention , Yb‘i’ 1 0 [Add affiliationfor firstcontributor], 1 j + eaaayi overview Meta-analysis eaaayi overview Meta-analysis + npitadbsln scores baseline and endpoint , otpnei,Reeves Kontopantelis, Reeves Kontopantelis, h ra identiﬁer trial the , u β [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,      [Add title,if necessary.] 2 2nd Qtr2nd 2nd Qtr2nd Qtr2nd 3rd Qtr 3rd 3rd Qtr 3rd Qtr 3rd [Add affiliation[Add forcontributor], second 4th Qtr 4th 4th Qtr 4th Qtr 4th 1st Qtr 1st 1st Qtr 1st Qtr 1st 1 [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] 1 rcia guide practical A rcia guide practical A 0% 0% 0% j [Poster title] nocons j = group

20% 20% 20% Yb RESULTS 40% 40% 40% 1 ; Carol Philips,PhD 3 [Add affiliationfor third contributor], 60% 60% 60% Summary Summary ipdforest ipdforest

if 80% 80% 80%

2 ; Jonathan Haas, RN, BSN, MHA BSN, RN, Haas, Jonathan ;

100% 100% 100% i studyid=‘i’ j + 4 [Add affiliationfor fourthcontributor] pinsprse siaino the of estimation suppresses option 3 , and, KimberlyB. Zimmerman, MD [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace, γ [E organization] or [Institution [Department] [Name] contact: please information additional For . . . . . list as[Add bulleted text ora paragraph.]     necessary.]if title, [Add

2 [Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub

------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet] j

ipdforest ipdforest

CONCLUSIONS title] [Graphic

RESULTS b 4

i j

title] [Graphic

i j j n eootherwise zero and Health Sciences Primary Care Research Group necessary.] if title, [Add [Add CONCLUSIONS: [Add text here.] RESULTS: [Add text here.] METHODS: [Add text here.] OBJECTIVE: [Add text here.] BACKGROUND: [Add text here.] TITLE

[Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace, text :

here.] admtilitret admtetetefc;fie ra-pcfi fet o baseline for effects trial-specific fixed effect; treatment random intercept; trial random 3 Model admtilitret admtetetefc;rno fet o baseline for effects random effect; treatment random intercept; trial random 4 Model

Label

Four BACKGROUND

[Repeat objective from from above.] objective [Repeat

OBJECTIVE ABSTRACT Label Three Label One

Label

Two

nSaaepesdas: expressed Stata In as: expressed Stata In trial): multi-centre (e.g. trial random assume are to intercepts is contentious, althought possibility, Another h aeiecudas aebe oelda a as modelled been have random-effect: also could baseline The [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,     necessary.]if title, [Add    necessary.]if title, [Add [Add title, if necessary.]if title, [Add [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] ...... [Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub tie .ru b| tdi:ru Yb, studyid:group || Yb i.group cov(uns) Y xtmixed || components variance-covariance Yb4 Yb3 Yb2 cov(uns) Yb1 cov(uns) i.group studyid:group, Y xtmixed correlation effects random assume to wiser Y sbfr,nnzr admefcscorrelations: effects random non-zero before, as Y β β β β β Lorum(kg) Wt ------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet] Nostrud: N Nostrud: Ipsum(wk)

F Unknown Unknown

W HB Irure: B Irure: O Proident H

Lorem

1 0 0 2 1

u cov u u i i

j j Excepteur METHODS j j j j j i 1 2 0

101 (476%) 121 (571%) 172 (811%) 18 (SD 10) 18 (SD 106 (50%) 79 (373%) 22 (104%) 31 ( 18 (85%) (n=212) 5 (24%) 9 (42%) 1 (05%) 2 (09%) ======Lkl j j j SD 0

Sint

5) ∼

[Replace the followingnames andtitles with thoseof the actual contributors:HelgeHoeing, PhD

∼ ∼ ∼ (

18 (667%) 26 (963%) 37 (SD 2) 37 (SD Controls 10 (37%) 17 (63%) 7 (259%)

β β 1 (37%) 1 (37%) 1 (37%) (SD 07) (SD (n=27) γ γ γ γ γ u 29 0 0 0

1 [Add affiliationfor firstcontributor], 0 0 1 0 1 0 2 0 N N N j j j ( + + + + + , eaaayi overview Meta-analysis eaaayi overview Meta-analysis ( ( ( + + 0 otpnei,Reeves Kontopantelis, Reeves Kontopantelis, u 0 0 0 σ , u u u u u losfrdsic siaino l RE all of estimation distinct for allows : 2 τ , τ , τ , β β [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,      [Add title,if necessary.] 2 2nd Qtr2nd 2nd Qtr2nd Qtr2nd 3rd Qtr 3rd 3rd Qtr 3rd Qtr 3rd [Add affiliation[Add forcontributor], second 4th Qtr 4th 4th Qtr 4th Qtr 4th 1st Qtr 1st 1st Qtr 1st Qtr 1st j 1 0 1 0 2 [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] 1 1 = ) j 2 rcia guide practical A rcia guide practical A 0% 0% 0% j j j j j 1 2 0 [Poster title] 2 2 2 j j )

group group 20% 20% 20% ) ) ) RESULTS 40% 40% 40% 1 ρ ; Carol Philips,PhD 3 [Add affiliationfor third contributor], 60% 60% 60% Summary Summary 2 ipdforest ipdforest cov u

80% 80% 80%

τ 2 ; Jonathan Haas, RN, BSN, MHA BSN, RN, Haas, Jonathan ; 0

100% 100% 100% 0 i i j j j τ ∼ 2 + + ( 4 [Add affiliationfor fourthcontributor] u 3 , and, KimberlyB. Zimmerman, MD [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace, 0 N [E organization] or [Institution [Department] [Name] contact: please information additional For . . . . . list as[Add bulleted text ora paragraph.]     necessary.]if title, [Add

[Add title, if necessary.]if title, [Add γ β title] [Graphic - mail address] mail [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] ...... j

2 [Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub 2 cov cov u , (

------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet] j

j u

Y ipdforest ipdforest

Y CONCLUSIONS title] [Graphic

j 1 τ , RESULTS b 4 b

j ∼ ( ( i = ) i

0 j j u u 2

+ ) +

title] [Graphic 1 0 N

j j , , ( ρτ u u 0 i i j j 2 1 τ , 0 j j τ = ) = ) 1 1 2 ) ρ ρ 3 1 τ τ ρ 1 0 τ τ 6= 2 1 0: Health Sciences Primary Care Research Group necessary.] if title, [Add [Add CONCLUSIONS: [Add text here.] RESULTS: [Add text here.] METHODS: [Add text here.] OBJECTIVE: [Add text here.] BACKGROUND: [Add text here.] TITLE

[Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace, text :

here.] neatosadcovariates and Interactions 5 Model General

Label

Four BACKGROUND

[Repeat objective from from above.] objective [Repeat

OBJECTIVE ABSTRACT Label Three Label One

Label

Two

r a fet r acltdwithin calculated plot forest are effects a Trial and table summary meta-analysis a Provides encountered be issues to non-convergence likely effect, more random a as modelled If as: expressed Stata In a as modelled effect be random can or term ﬁxed interaction an or covariate A etdwti rasada and trials patients within with nested regression, two-level effects mixed uses ipdforest age treatment: both the for with effects interaction ﬁxed its include and to 2 we Model expand age variable can standardised and continuous Assuming a aclt n eotbt anaditrcineffects interaction and main both report and calculate Can vrl fets n aineetmtsaeetatdfrom regression extracted preceding are the estimates variance and effect(s) Overall [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,     necessary.]if title, [Add    necessary.]if title, [Add [Add title, if necessary.]if title, [Add [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] ...... [Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub tie .ru .tdi b b b Yb4 Yb3 nocons Yb2 studyid:group, Yb1 || i.studyid i.group#c.age i.group age Y xtmixed β oitcmdl( model logistic or ( model linear Y Lorum(kg) Wt ------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet] Nostrud: N Nostrud: Ipsum(wk)

F Unknown Unknown

W HB Irure: B Irure: O Proident H

Lorem

j Excepteur METHODS j

101 (476%) 121 (571%) 172 (811%) 18 (SD 10) 18 (SD 106 (50%) 79 (373%) 22 (104%) 31 ( 18 (85%) (n=212) 5 (24%) 9 (42%) 1 (05%) 2 (09%) = = Lkl SD 0

Sint

[Replace the followingnames andtitles with thoseof the actual contributors:HelgeHoeing, PhD

18 (667%) 26 (963%) 37 (SD 2) 37 (SD Controls 10 (37%) 17 (63%) 7 (259%)

γ 1 (37%) 1 (37%) 1 (37%) (SD 07) (SD (n=27) γ 29 0 0 0

1 0 [Add affiliationfor firstcontributor], 1 j + + eaaayi overview Meta-analysis eaaayi overview Meta-analysis sise olwn nIDmt-nlssthat meta-analysis IPD an following issued is otpnei,Reeves Kontopantelis, otpnei,Reeves Kontopantelis, β u [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,      [Add title,if necessary.] 2 2nd Qtr2nd 2nd Qtr2nd Qtr2nd 3rd Qtr 3rd 3rd Qtr 3rd Qtr 3rd [Add affiliation[Add forcontributor], second 4th Qtr 4th 4th Qtr 4th Qtr 4th 1st Qtr 1st 1st Qtr 1st Qtr 1st 1 1 [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] rcia guide practical A rcia guide practical A 0% 0% 0% j j [Poster title] group xtmixed

20% 20% 20% xtmelogit RESULTS 40% 40% 40% 1 ; Carol Philips,PhD 3 [Add affiliationfor third contributor], 60% 60% 60% Summary Summary ipdforest ipdforest

80% 80% 80%

2 ; Jonathan Haas, RN, BSN, MHA BSN, RN, Haas, Jonathan ;

i 100% 100% 100% j + 4 [Add affiliationfor fourthcontributor] γ ) 3 , and, KimberlyB. Zimmerman, MD [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace, [E organization] or [Institution [Department] [Name] contact: please information additional For . . . . . list as[Add bulleted text ora paragraph.]     necessary.]if title, [Add

[Add title, if necessary.]if title, [Add title] [Graphic 2 - mail address] mail [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] ......

j [Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub Y

------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet]

ipdforest example methods ipdforest

CONCLUSIONS title] [Graphic

b )

RESULTS i 4

title] [Graphic

ipdforest γ 3 age i j + γ 4 group i j age i j + i j Health Sciences Primary Care Research Group necessary.] if title, [Add [Add CONCLUSIONS: [Add text here.] RESULTS: [Add text here.] METHODS: [Add text here.] OBJECTIVE: [Add text here.] BACKGROUND: [Add text here.] TITLE

[Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace, text :

here.] Process siaindetails Estimation

Label

Four BACKGROUND

[Repeat objective from from above.] objective [Repeat

OBJECTIVE ABSTRACT Label Three Label One

Label

Two

xtmelogit Following siae ne w-ee oe)i itemr complex. more little a coefficient is the model) two-level by given under and estimated trials across coefficient constant (regression assumed covariate fixed-effect a for Control specifications same the using recommend strongly we But logistic or regressions linear one-level using errors standard ipdforest oait sa needn aibei ahregression each in variable the independent including an by as trial) covariate by vary the to allowing coefficient (i.e. regression covariate random-effects a effects, for trial controls individual of estimation the In random-effects) or fixed- the as in specification covariates (e.g. included command over control full has User regression the two-level in preceding specified were that covariates random-effects ipdforest [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,     necessary.]if title, [Add    necessary.]if title, [Add [Add title, if necessary.]if title, [Add [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] ...... [Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub o iayotoeteeuvln sahee through achieved analysis the is to of equivalent prior use the step outcome first binary a a in For values the its of to contribution covariates the fixed subtracting by adjusted outcome is continuous variable regression the a and for regress value under fixed coefficient a specify to possible Not Lorum(kg) Wt ------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet] Nostrud: N Nostrud: Ipsum(wk)

F Unknown Unknown

W HB Irure: B Irure: O Proident H

Lorem

Excepteur METHODS

101 (476%) 121 (571%) 172 (811%) 18 (SD 10) 18 (SD 106 (50%) 79 (373%) 22 (104%) 31 ( 18 (85%) (n=212) 5 (24%) 9 (42%) 1 (05%) 2 (09%) Lkl SD 0

Sint

[Replace the followingnames andtitles with thoseof the actual contributors:HelgeHoeing, PhD

18 (667%) 26 (963%) 37 (SD 2) 37 (SD Controls 10 (37%) 17 (63%) 7 (259%)

1 (37%) 1 (37%) 1 (37%) (SD 07) (SD (n=27) 29 xtmixed 0 0 0

1 [Add affiliationfor firstcontributor], , eaaayi overview Meta-analysis eaaayi overview Meta-analysis siae niiultilefcsadtheir and effects trial individual estimates otosteergesosfrﬁe-or ﬁxed- for regressions these controls otpnei,Reeves Kontopantelis, Reeves Kontopantelis, logit offset [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,      [Add title,if necessary.] 2 2nd Qtr2nd 2nd Qtr2nd Qtr2nd 3rd Qtr 3rd 3rd Qtr 3rd Qtr 3rd [Add affiliation[Add forcontributor], second 4th Qtr 4th 4th Qtr 4th Qtr 4th 1st Qtr 1st 1st Qtr 1st Qtr 1st [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] rcia guide practical A rcia guide practical A 0% 0% 0% [Poster title]

20% 20% 20% RESULTS 40% 40% 40% 1 , ; Carol Philips,PhD 3 [Add affiliationfor third contributor], 60% 60% 60% Summary Summary ipdforest ipdforest regress sue,frec trial each for used, is

80% 80% 80%

2 ; Jonathan Haas, RN, BSN, MHA BSN, RN, Haas, Jonathan ; pinin option

[Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub

------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet]

ipdforest ipdforest example methods example methods

CONCLUSIONS title] [Graphic

RESULTS 4

logit sue n following and used is

title] [Graphic

ipdforest Health Sciences Primary Care Research Group necessary.] if title, [Add [Add CONCLUSIONS: [Add text here.] RESULTS: [Add text here.] METHODS: [Add text here.] OBJECTIVE: [Add text here.] BACKGROUND: [Add text here.] TITLE

[Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace, text :

here.] atI part Heterogeneity atII part Heterogeneity

Label

Four BACKGROUND

[Repeat objective from from above.] objective [Repeat

OBJECTIVE ABSTRACT Label Three Label One

Label

Two

ae nthe on based nevli eotdudrbt models. both under reported is interval estimate variability Between-trial computed be cannot measures heterogeneity under reported within-trial not the is of variance estimate an outcomes, binary For outcomes, continuous For ewe-ra variability Between-trial ult,otoe rpopulations design, or trial outcomes in quality, differences from arises heterogeneity, as eaentcluaiga P eso fCochran’s of version IPD an calculating not are We orthodox eo eut ihtetoapoce converge approaches two to the close with be results to zero, estimated is variance between-trial When one ﬁxed-effect conservative the more than a approach is model of random-effects levels a low adopting even account into taking Besides, trials of number the when performance [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,     necessary.]if title, [Add    necessary.]if title, [Add [Add title, if necessary.]if title, [Add [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] ...... [Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub Lorum(kg) Wt ------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet] Nostrud: N Nostrud: Ipsum(wk)

F Unknown Unknown

W HB Irure: B Irure: O Proident H

Lorem

Excepteur METHODS

101 (476%) 121 (571%) 172 (811%) 18 (SD 10) 18 (SD 106 (50%) 79 (373%) 22 (104%) 31 ( 18 (85%) (n=212) 5 (24%) 9 (42%) 1 (05%) 2 (09%) Lkl SD 0

Sint

[Replace the followingnames andtitles with thoseof the actual contributors:HelgeHoeing, PhD

χ 18 (667%) 26 (963%) 37 (SD 2) 37 (SD Controls 10 (37%) 17 (63%) 7 (259%)

1 (37%) 1 (37%) 1 (37%) (SD 07) (SD (n=27) 29 0 0 0

1 [Add affiliationfor firstcontributor], k 2 − eaaayi overview Meta-analysis eaaayi overview Meta-analysis otpnei,Reeves Kontopantelis, Reeves Kontopantelis, 1 xtmixed ooeet et osdrn t poor its considering test, homogeneity [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,      [Add title,if necessary.] 2 2nd Qtr2nd 2nd Qtr2nd Qtr2nd 3rd Qtr 3rd 3rd Qtr 3rd Qtr 3rd [Add affiliation[Add forcontributor], second 4th Qtr 4th 4th Qtr 4th Qtr 4th 1st Qtr 1st 1st Qtr 1st Qtr 1st [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] rcia guide practical A rcia guide practical A 0% 0% 0% [Poster title]

20% 20% 20% RESULTS 40% 40% 40% 1 ; Carol Philips,PhD 3 [Add affiliationfor third contributor], 60% 60% 60% Summary Summary ipdforest ipdforest

80% 80% 80%

2 ; Jonathan Haas, RN, BSN, MHA BSN, RN, Haas, Jonathan ;

100% 100% 100% output τ 4 [Add affiliationfor fourthcontributor] 2 3 , and, KimberlyB. Zimmerman, MD [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace, [E organization] or [Institution [Department] [Name] contact: please information additional For . . . . . list as[Add bulleted text ora paragraph.]     necessary.]if title, [Add

[Add title, if necessary.]if title, [Add title] [Graphic ipdforest - mail address] mail ntetetetefc,known effect, treatment the in [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] ......

[Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub

------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet]

ipdforest ipdforest example methods example methods

CONCLUSIONS title] [Graphic

RESULTS 4

xtmelogit

title] [Graphic τ

ˆ 2 n t conﬁdence its and k reports, ssmall is n hence and τ I 2 2 by and Q the , H M 2 , Health Sciences Primary Care Research Group necessary.] if title, [Add [Add CONCLUSIONS: [Add text here.] RESULTS: [Add text here.] METHODS: [Add text here.] OBJECTIVE: [Add text here.] BACKGROUND: [Add text here.] TITLE

[Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace, text :

here.] ersinintervention Depression Dataset

Label

Four BACKGROUND

[Repeat objective from from above.] objective [Repeat

OBJECTIVE ABSTRACT Label Three Label One

Label

Two eCa9fot%.gCn ucm aeie ra 9 trial 5 baseline, trial outcome 2 baseline, Cont trial outcome 1 baseline, Cont trial outcome endpoint baseline, Cont outcome, baseline outcome Continuous outcome, Cont 9 Continuous trial 5 baseline, trial outcome 2 baseline, Bin trial outcome 1 baseline, Bin trial outcome endpoint baseline, Bin outcome, baseline outcome Binary outcome, Bin years Binary in %9.0g Age %9.0g float %9.0g float identifier Patient %9.0g %9.0g float %9.0g Gender float float float depCbas9 %9.0g group Intervention/control depCbas5 %9.0g sexlbl byte depCbas2 %9.0g identifier Study byte depCbas1 %9.0g %9.0g grplbl %9.0g byte depCbas %10.0g %10.0g byte byte depC float byte depBbas9 byte stid %20.0g depBbas5 %8.0g depBbas2 byte depBbas1 int %22.0g depBbas depB byte age sex group patid studyid ipdforest_example.dta from data Contains describe . ipdforest_example.dta, use . otdb:suydpatid studyid by: Sorted label variable label format type name variable

as 76Fb21 11:14 2012 Feb 6 17 20,202 size: vars: b:518 obs: hl epn h oaitsa hi culvalues actual their at covariates the variables, keeping outcome while and binary names & author continuous fake random use generated we yet; published patients not 518 Results for values endpoint and baseline outcome continuous membership, gender, group age, control/intervention of terms in information Complete oitcIDmt-nlss olwdby followed meta-analysis, IPD Logistic variability between-trial and endpoint scores and baseline between correlation Introduced trials intervention depression the apply We [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,     necessary.]if title, [Add    necessary.]if title, [Add [Add title, if necessary.]if title, [Add [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] ...... [Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub Lorum(kg) Wt ------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet] Nostrud: N Nostrud: Ipsum(wk)

F Unknown Unknown

W HB Irure: B Irure: O Proident H

Lorem

Excepteur METHODS

trg ipa value display storage 101 (476%) 121 (571%) 172 (811%) 18 (SD 10) 18 (SD 106 (50%) 79 (373%) 22 (104%) 31 ( 18 (85%) (n=212) 5 (24%) 9 (42%) 1 (05%) 2 (09%) Lkl SD 0

Sint

[Replace the followingnames andtitles with thoseof the actual contributors:HelgeHoeing, PhD

18 (667%) 26 (963%) 37 (SD 2) 37 (SD Controls 10 (37%) 17 (63%) 7 (259%)

1 (37%) 1 (37%) 1 (37%) (SD 07) (SD (n=27) 29 0 0 0

1 [Add affiliationfor firstcontributor], eaaayi overview Meta-analysis eaaayi overview Meta-analysis otpnei,Reeves Kontopantelis, otpnei,Reeves Kontopantelis, ipdforest [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,      [Add title,if necessary.] 2 2nd Qtr2nd 2nd Qtr2nd Qtr2nd 3rd Qtr 3rd 3rd Qtr 3rd Qtr 3rd [Add affiliation[Add forcontributor], second 4th Qtr 4th 4th Qtr 4th Qtr 4th 1st Qtr 1st 1st Qtr 1st Qtr 1st [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] rcia guide practical A rcia guide practical A 0% 0% 0% [Poster title]

20% 20% 20% RESULTS 40% 40% 40% 1 ; Carol Philips,PhD 3 [Add affiliationfor third contributor], 60% 60% 60% Summary Summary ipdforest ipdforest

80% 80% 80%

2 ; Jonathan Haas, RN, BSN, MHA BSN, RN, Haas, Jonathan ;

[Add title, if necessary.]if title, [Add title] [Graphic omn oadtsto 4 of dataset a to command - mail address] mail [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] ......

[Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub

------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet]

ipdforest example methods ipdforest example methods

CONCLUSIONS title] [Graphic

RESULTS 4

title] [Graphic

[Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace, text :

here.] xdtilitret;fie ra fet o aeie admtetetadaeeffects age and treatment random baseline; for effects trial fixed intercepts; model trial regression fixed logistic effects Mixed oeln anefc n interaction and effect main modelling ipdforest

Label

Four BACKGROUND

[Repeat objective from from above.] objective [Repeat

OBJECTIVE ABSTRACT Label Three Label One

Label tdi:Independent studyid: 42.06 0.0000 group#c.agec = = 4 chi2(11) Wald chi2 > Prob = 518 groups of Number = obs of Number 7 -326.55747 = likelihood = Log points Integration i depBbas9 depBbas5 or studyid depBbas2 nocons variable: regression depBbas1 var Group logistic i.studyid agec, Mixed-effects sex studyid:group agec || group .group#c.agec depB > xtmelogit .

opn 2009 Kompany 2008 Silva 2004 Richards 2005 Hart ipdforest and method) agec) (ML x xtmelogit (group using effect results Interaction meta-analysis One-stage effect Overall 2009 Kompany 2008 Silva 2004 Richards 2005 Hart ipdforest and method) (ML xtmelogit (group) using effect or results Main ia(agec) meta-analysis re(agec) One-stage fe(sex) group, ipdforest . a^ est tau^2 H^2 (%) I^2 Measures Heterogeneity effect Overall

Two admefcsParameters Random-effects

depBbas9 depBbas5 depBbas2 depBbas1 studyid _cons group agec depB sex Study Study 1 9 5 2 [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,     necessary.]if title, [Add    necessary.]if title, [Add [Add title, if necessary.]if title, [Add [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] ...... dsRtoSd r.zP||[5 of Interval] Conf. [95% P>|z| z Err. Std. Ratio Odds [Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub Lorum(kg) Wt ------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet] Nostrud: N Nostrud: Ipsum(wk) 5374.384 13 .7 26421.293993 1.044385 .2366472 .9801858 3.936262 0.172 9.823007 0.469 -1.37 10.12574 .8990569 7.987253 .5802064 0.72 .2398342 1.982385 0.093 3.673735 1.244587 .5533714 0.228 3.387799 .0163748 1.68 0.000 3.057303 .4469619 1.21 1.011776 0.015 .189601 3.60 .7086507 .3606166 2.42 0.644 1.722993 1.087912 1.881203 1.863908 0.763 0.46 2.71978 1.010403 2.387336 0.929 1.495281 4.480302 .4656639 -0.30 0.09 3.152908 .9637288 .6886057 1.245894 .5894511 0.116 1.281413 .5725516 0.270 .8014551 0.002 -1.57 1.050007 -1.10 3.06 .1540753 .0119059 .7117592 .3666167 .9867902 1.840804

F Unknown Unknown

W HB Irure: B Irure: O Proident H var(group)

Lorem

var(agec)

Excepteur METHODS

101 (476%) 121 (571%) 172 (811%) 18 (SD 10) 18 (SD 106 (50%) 79 (373%) 22 (104%) 31 ( 18 (85%) (n=212) 5 (24%) 9 (42%) 1 (05%) 2 (09%) Lkl SD 0

Sint fet[5 of nevl Weight % Interval] Conf. [95% Effect fet[5 of nevl Weight % Interval] Conf. [95% Effect

[Replace the followingnames andtitles with thoseof the actual contributors:HelgeHoeing, PhD

.1 .8 .4 100.00 Interval] 41.31 Conf. 8.11 [95% 1.044 30.69 value 19.88 1.144 0.980 1.098 1.055 1.015 1.049 0.888 1.012 0.937 0.901 1.077 0.987 0.995 100.00 0.972 41.31 8.11 2.720 30.69 19.88 3.707 1.246 9.676 5.545 0.969 4.765 0.748 1.841 1.336 0.942 1.895 2.690 2.722 2.118

.0 .0 . 0.000 0.000

18 (667%) 26 (963%) 37 (SD 2) 37 (SD Controls 10 (37%) 17 (63%) 7 (259%)

1 (37%) 1 (37%) 1 (37%) (SD 07) (SD (n=27) 29 0 0 0

1 [Add affiliationfor firstcontributor], . . .9-844e1 . . 0 0 Interval] 4.40e-11 Conf. [95% 2.43e-11 5.99e-18 8.86e-21 Err. Std. Estimate eaaayi overview Meta-analysis eaaayi overview Meta-analysis otpnei,Reeves Kontopantelis, otpnei,Reeves Kontopantelis, [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,      [Add title,if necessary.] 2 2nd Qtr2nd 2nd Qtr2nd Qtr2nd 3rd Qtr 3rd 3rd Qtr 3rd Qtr 3rd [Add affiliation[Add forcontributor], second 4th Qtr 4th 4th Qtr 4th Qtr 4th 1st Qtr 1st 1st Qtr 1st Qtr 1st [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] rcia guide practical A rcia guide practical A 0% 0% 0% [Poster title]

20% 20% 20% RESULTS 40% 40% 40% b e ru:mn=42 = min group: per Obs 1 ; Carol Philips,PhD 3 [Add affiliationfor third contributor], 60% 60% 60% Summary Summary ipdforest ipdforest

80% 80% 80%

2 ; Jonathan Haas, RN, BSN, MHA BSN, RN, Haas, Jonathan ;

100% 100% 100% 4 [Add affiliationfor fourthcontributor] a 214 129.5 = max = avg 3 , and, KimberlyB. Zimmerman, MD [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace, [E organization] or [Institution [Department] [Name] contact: please information additional For . . . . . list as[Add bulleted text ora paragraph.]     necessary.]if title, [Add

[Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub

------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet]

ipdforest example methods ipdforest example methods

CONCLUSIONS title] [Graphic

RESULTS 4

title] [Graphic

[Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace, text

Kompany 2009 Studies : Richards 2004

here.] Overall effect anefc n interaction and effect main plots Forest htt aehome take to What

Silva 2008

Hart 2005 Label

Four BACKGROUND

[Repeat objective from from above.] objective [Repeat

OBJECTIVE ABSTRACT Label Three Label One

Label

Two

1 tcnda ihmi n l ye fitrcineffects interaction of types all and (binary main with deal can It e ifrn prahseitfrcnutn one-stage conducting meta-analysis for IPD exist approaches different few A commands The the through cope can Stata 2 [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,     necessary.]if title, [Add    necessary.]if title, [Add [Add title, if necessary.]if title, [Add [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] ...... [Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub rdc aiirad‘xetd forest-plots ‘expected’ and familiar tables produce meta-analysis standard in results display effects trial calculate ipdforest 3 Lorum(kg) Wt ------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet] Nostrud: N Nostrud: Ipsum(wk)

F Unknown Unknown

W HB Irure: B Irure: O Proident H

Lorem

Effect sizesandCIs(ORs) Excepteur METHODS ×

101 (476%) 121 (571%) 172 (811%) 18 (SD 10) 18 (SD 106 (50%) 79 (373%) 22 (104%) 31 ( 18 (85%) (n=212) 5 (24%) 9 (42%) 1 (05%) 2 (09%) Main effect(group) 4 Lkl SD 0

Sint

[Replace the followingnames andtitles with thoseof the actual contributors:HelgeHoeing, PhD

otnu,binary continous,

18 (667%) 26 (963%) 37 (SD 2) 37 (SD Controls 10 (37%) 17 (63%) 7 (259%)

1 (37%) 1 (37%) 1 (37%) (SD 07) (SD (n=27) 29 0 0 0

5 1 [Add affiliationfor firstcontributor], eaaayi overview Meta-analysis eaaayi overview Meta-analysis otpnei,Reeves Kontopantelis, otpnei,Reeves Kontopantelis, 6 [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,      [Add title,if necessary.] 2 2nd Qtr2nd 2nd Qtr2nd Qtr2nd 3rd Qtr 3rd 3rd Qtr 3rd Qtr 3rd [Add affiliation[Add forcontributor], second 4th Qtr 4th 4th Qtr 4th Qtr 4th 1st Qtr 1st 1st Qtr 1st Qtr 1st [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] rcia guide practical A rcia guide practical A 0% 0% 0% 7 [Poster title] omn ist epmeta-analysts help to aims command

20% 20% 20% RESULTS 40% 40% 40% 8 1 ; Carol Philips,PhD 3 [Add affiliationfor third contributor], 60% 60% 60% Summary Summary ipdforest ipdforest

80% 80% 80%

2 ; Jonathan Haas, RN, BSN, MHA BSN, RN, Haas, Jonathan ;

9 100% 100% 100% 4 [Add affiliationfor fourthcontributor] 10 × 3 , and, KimberlyB. Zimmerman, MD [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace, [E organization] or [Institution [Department] [Name] contact: please information additional For . . . . . list as[Add bulleted text ora paragraph.]     necessary.]if title, [Add

[Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub iay binary binary, xtmixed

------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet]

ipdforest example methods ipdforest

Kompany 2009 Studies CONCLUSIONS title] [Graphic

Richards 2004 Overall effect

RESULTS Silva 2008 4 Hart 2005

title] [Graphic

0 .2 n the and .4 × categorical) Interaction effect(groupxagec) Effect sizesandCIs(ORs) .6 xtmelogit .8 1 1.2 1.4 Health Sciences Primary Care Research Group necessary.] if title, [Add [Add CONCLUSIONS: [Add text here.] RESULTS: [Add text here.] METHODS: [Add text here.] OBJECTIVE: [Add text here.] BACKGROUND: [Add text here.] TITLE

[Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace, text :

here.]

Label

Four BACKGROUND

[Repeat objective from from above.] objective [Repeat

OBJECTIVE ABSTRACT Label Three Label One

Label

Two

[email protected] suggestions: Comments, [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,     necessary.]if title, [Add    necessary.]if title, [Add [Add title, if necessary.]if title, [Add [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add description of key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] ...... [Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub Lorum(kg) Wt ------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet] Nostrud: N Nostrud: Ipsum(wk)

F Unknown Unknown

W HB Irure: B Irure: O Proident H

Lorem

Excepteur METHODS

101 (476%) 121 (571%) 172 (811%) 18 (SD 10) 18 (SD 106 (50%) 79 (373%) 22 (104%) 31 ( 18 (85%) (n=212) 5 (24%) 9 (42%) 1 (05%) 2 (09%) Lkl SD 0

Sint

[Replace the followingnames andtitles with thoseof the actual contributors:HelgeHoeing, PhD

18 (667%) 26 (963%) 37 (SD 2) 37 (SD Controls 10 (37%) 17 (63%) 7 (259%)

1 (37%) 1 (37%) 1 (37%) (SD 07) (SD (n=27) 29 0 0 0

1 [Add affiliationfor firstcontributor], otpnei,Reeves Kontopantelis, [Replace, move, resize, or delete graphic, as as necessary.] graphic, or delete resize, move, [Replace,      [Add title,if necessary.] 2 2nd Qtr2nd 2nd Qtr2nd Qtr2nd 3rd Qtr 3rd 3rd Qtr 3rd Qtr 3rd [Add affiliation[Add forcontributor], second 4th Qtr 4th 4th Qtr 4th Qtr 4th 1st Qtr 1st 1st Qtr 1st Qtr 1st [Add key point.] [Add key point.] [Add key point.] [Add key point.] [Add key point.] 0% 0% 0% [Poster title]

20% 20% 20% RESULTS 40% 40% 40% 1 ; Carol Philips,PhD 3 [Add affiliationfor third contributor], 60% 60% 60% Appendix

80% 80% 80%

2 ; Jonathan Haas, RN, BSN, MHA BSN, RN, Haas, Jonathan ;

[Sub [Sub [Sub [Sub [Sub [Sub [Sub [Sub

------bullet] bullet] bullet] bullet] bullet] bullet] bullet] bullet]

ipdforest you! Thank

CONCLUSIONS title] [Graphic

RESULTS 4

title] [Graphic